RESUMO
BACKGROUND: High incidence of treatable oral conditions has been reported among palliative patients. However, a large proportion of palliative patients lose their ability to communicate their sufferings. Therefore, it may lead to under-reporting of oral conditions among these patients. This review systematically synthesized the published evidence on the presence of oral conditions among palliative patients, the impact, management, and challenges in treating these conditions. METHODS: An integrative review was undertaken with defined search strategy from five databases and manual search through key journals and reference list. Studies which focused on oral conditions of palliative patients and published between years 2000 to 2017 were included. RESULTS: Xerostomia, oral candidiasis and dysphagia were the three most common oral conditions among palliative patients, followed by mucositis, orofacial pain, taste change and ulceration. We also found social and functional impact of having certain oral conditions among these patients. In terms of management, complementary therapies such as acupuncture has been used but not well explored. The lack of knowledge among healthcare providers also posed as a challenge in treating oral conditions among palliative patients. CONCLUSIONS: This review is first in its kind to systematically synthesize the published evidence regarding the impact, management and challenges in managing oral conditions among palliative patients. Although there is still lack of study investigating palliative oral care among specific group of patients such as patients with dementia, geriatric or pediatric advanced cancer patients, this review has however provided baseline knowledge that may guide health care professionals in palliative settings.
Assuntos
Saúde Bucal , Úlceras Orais/etiologia , Cuidados Paliativos/métodos , Doente Terminal , Xerostomia/etiologia , Idoso , Criança , Humanos , Doenças da Boca/etiologiaRESUMO
BACKGROUND AND OBJECTIVE: Various clinical and animal studies have applied low-level laser therapy (LLLT) to treat oral ulcers. However, most previous studies applied lasers with small pinpoint irradiation, which required multiple laser irradiations to cover the complete extent of the ulcer. The objective of this study was to evaluate the effect of LLLT using a 635 nm diode laser via a transoral device to cover the whole lesion on oral ulcers in an animal model. STUDY DESIGN/MATERIALS AND METHODS: An animal model of oral ulcers was developed with a 6 mm skin punch in the right buccal mucosa of Wistar rats (males, body weight 200-250 g). Three days after the mucosal injury, LLLT (spot size 2 cm2 ) was conducted once a day for 5 days. Twenty-eight rats were randomly assigned into four groups according to energy density (control group, 5, 20, 75 J/cm2 ). The size of the ulcers was measured and histologic analysis were performed ten days after the initial mucosal injury. RESULTS: The mean size of the oral ulcers was significantly smaller in rats treated with an energy density of 20 J/cm2 than that of any other group (control group or energy densities of 5 or 75 J/cm2 ). The irradiation of oral ulcers with an energy density of 20 J/cm2 accelerated the oral mucosa wound healing process and decreased inflammation and granulation tissue, resulting in good reepithelization. However, the histologic outcomes of rats irradiated with energy densities of 5 or 75 J/cm2 were comparable with those of the control group. CONCLUSION: LLLT using a 635 nm diode laser for oral ulcers with a transoral cylindrical device for wide light distribution may accelerate the wound healing process. LLLT with large-surface irradiation may be a substitute for previous LLLT for oral mucosal lesions conducted in a punctuate manner. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.
Assuntos
Terapia com Luz de Baixa Intensidade , Úlceras Orais , Animais , Lasers Semicondutores/uso terapêutico , Masculino , Úlceras Orais/etiologia , Úlceras Orais/radioterapia , Ratos , Ratos Wistar , RoedoresRESUMO
A 39-year-old woman sought specialized treatment complaining of a large, painful oral ulcer in the right buccal vestibule after receiving emergency endodontic treatment 3 days earlier. The patient reported that the tooth, the mandibular right first premolar, was not isolated with a rubber dam and that she felt the extrusion of a liquid in the buccal tissues. Clinically, a necrotic area with raised erythematous borders was observed in the mandibular right side. The clinical diagnosis was a chemically induced ulcer caused by a sodium hypochlorite accident. Dexamethasone and amoxicillin were prescribed to control pain and prevent secondary infection. The large size of the lesion was an indication for application of low-level laser therapy (LLLT), which was delivered at a wavelength of 685 nm (output power, 30 mW; power density, 0.5 mW/cm2 ; energy density, 6 J/cm2 ) every 2 days for a total of 6 sessions. The LLLT was applied to the necrotic area with a punctual mode (2 points) for 12 seconds per point. The patient reported a substantial reduction in pain after the second application, and the wound was completely healed after 6 sessions. The results observed in this patient suggest that LLLT could aid patients in recovering from NaOCl-related lesions.
Assuntos
Terapia com Luz de Baixa Intensidade , Úlceras Orais , Hipoclorito de Sódio/efeitos adversos , Acidentes , Adulto , Dente Pré-Molar , Feminino , Humanos , Úlceras Orais/etiologia , Úlceras Orais/terapiaRESUMO
STATEMENT OF PROBLEM: Management of denture-related traumatic ulcers using ozone may improve tissue healing and reduce patient pain and discomfort. PURPOSE: The purpose of this clinical investigation was to assess the efficacy of ozone in the treatment of denture-related traumatic ulcers. MATERIAL AND METHODS: Seventy-five participants (study group) with denture-related traumatic ulcers were evaluated in this blinded, controlled cohort observational investigation. A control group (n=75) of participants with denture-related traumatic ulcers who matched the study group in sex and age were also recruited. Ulcers were treated with ozone gas for 60 seconds in the study group and with air for 60 seconds in the control group. Pain levels were evaluated by means of a visual analog scale (VAS), and ulcer sizes were measured in each participant at experiment baseline and each day for 15 days. Ulcer duration was established by calculating the period it took to completely heal and disappear. Major outcome measurements were ulcer duration, ulcer size, and levels of pain. RESULTS: Ulcer size decreased from day 2 in the study group (after ozone application) (P≤.01) and from day 4 in the controls (P≤.001). Recorded pain levels decreased from the first day soon after ozone application in the study group (P≤.001) and from day 3 in the controls (P<.001). Ulcer duration, ulcer size from day 3 to day 10, and reported pain levels from day 1 to day 10 decreased more in the study group (P≤.004). CONCLUSIONS: Exposure of denture-related traumatic ulcers to 60 seconds of ozone gas was associated with better ulcer healing and decreased pain levels, ulcer size, and ulcer duration.
Assuntos
Prótese Total/efeitos adversos , Úlceras Orais/tratamento farmacológico , Úlceras Orais/etiologia , Ozônio/uso terapêutico , Idoso , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Úlceras Orais/patologia , Ozônio/administração & dosagem , Manejo da Dor/métodos , Resultado do TratamentoRESUMO
Radiation combined injury, a life-threatening condition, has higher mortality than simple radiation injury. The aim of the present study was to analyze the efficiency of Aloe vera and silver nanoparticles in improving the healing of ulcerated oral mucosa after irradiation. Thirty male Albino mice were divided into five groups: control, radiation, Aloe vera (AV), silver nanoparticles (NS), and AV+NS. The mice were exposed to whole body 6Gy gamma-radiation. After one hour, 20% acetic acid was injected into the submucosal layer of the lower lip for ulcer induction. The animals received topical treatment with the assigned substances for 5 days. Lip specimens were subjected to hematoxylin and eosin and anti alpha-smooth muscle actin immunohistochemical staining. Results demonstrated occurance of ulcer three days post irradiation in all groups except in the AV+NS group where only epithelial detachment was developed. After seven days, data revealed persistent ulcer in radiation group, and almost normal epithelium in the AV+NS group. A significant reduction of epithelial thickness was detected in all groups at the third day as compared to control. At the seventh day, only the AV+NS group restored the epithelial thickness. Area percent of alpha-smooth muscle actin expression was significantly decreased in radiation group at the third day followed by significant increase at the seventh day. However, all treatment groups showed significant increase in alpha-smooth muscle actin at the third day, which decreased to normal level at the seventh day. Our study demonstrated the efficiency of Aloe vera and silver nanoparticles in enhancing ulcer healing after irradiation.
Assuntos
Aloe/química , Raios gama/efeitos adversos , Nanopartículas Metálicas/uso terapêutico , Úlceras Orais/tratamento farmacológico , Úlceras Orais/etiologia , Lesões Experimentais por Radiação/tratamento farmacológico , Prata/uso terapêutico , Ácido Acético , Actinas/análise , Administração Tópica , Animais , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/efeitos da radiação , Fibroblastos/efeitos dos fármacos , Imuno-Histoquímica , Masculino , Camundongos , Microscopia Eletrônica de Transmissão , Úlceras Orais/patologia , Lesões Experimentais por Radiação/patologia , Valores de Referência , Reprodutibilidade dos Testes , Fatores de Tempo , Resultado do Tratamento , Cicatrização/efeitos dos fármacosRESUMO
Abstract Radiation combined injury, a life-threatening condition, has higher mortality than simple radiation injury. The aim of the present study was to analyze the efficiency of Aloe vera and silver nanoparticles in improving the healing of ulcerated oral mucosa after irradiation. Thirty male Albino mice were divided into five groups: control, radiation, Aloe vera (AV), silver nanoparticles (NS), and AV+NS. The mice were exposed to whole body 6Gy gamma-radiation. After one hour, 20% acetic acid was injected into the submucosal layer of the lower lip for ulcer induction. The animals received topical treatment with the assigned substances for 5 days. Lip specimens were subjected to hematoxylin and eosin and anti alpha-smooth muscle actin immunohistochemical staining. Results demonstrated occurance of ulcer three days post irradiation in all groups except in the AV+NS group where only epithelial detachment was developed. After seven days, data revealed persistent ulcer in radiation group, and almost normal epithelium in the AV+NS group. A significant reduction of epithelial thickness was detected in all groups at the third day as compared to control. At the seventh day, only the AV+NS group restored the epithelial thickness. Area percent of alpha-smooth muscle actin expression was significantly decreased in radiation group at the third day followed by significant increase at the seventh day. However, all treatment groups showed significant increase in alpha-smooth muscle actin at the third day, which decreased to normal level at the seventh day. Our study demonstrated the efficiency of Aloe vera and silver nanoparticles in enhancing ulcer healing after irradiation.
Assuntos
Animais , Masculino , Camundongos , Aloe/química , Raios gama/efeitos adversos , Nanopartículas Metálicas/uso terapêutico , Úlceras Orais/tratamento farmacológico , Úlceras Orais/etiologia , Lesões Experimentais por Radiação/tratamento farmacológico , Prata/uso terapêutico , Ácido Acético , Actinas/análise , Administração Tópica , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/efeitos da radiação , Fibroblastos/efeitos dos fármacos , Imuno-Histoquímica , Microscopia Eletrônica de Transmissão , Úlceras Orais/patologia , Lesões Experimentais por Radiação/patologia , Valores de Referência , Reprodutibilidade dos Testes , Fatores de Tempo , Resultado do Tratamento , Cicatrização/efeitos dos fármacosRESUMO
Tumor-induced osteomalacia (TIO) is a rare cause of hypophosphatemia involving overproduction of fibroblast growth factor 23. TIO has been described largely in adults with small mesenchymal tumors. We report a case of TIO in a child who presented with knee pain and radiographic findings concerning for rickets, and was found to have maxillomandibular giant cell lesions. The patient was treated with oral phosphorus and calcitriol, surgical debulking, and intralesional corticosteroids, which resulted in tumor regression and normalization of serum fibroblast growth factor 23 and phosphorus. This case illustrates the occurrence of this rare paraneoplastic syndrome in children and adds to our knowledge about clinical manifestations and pathologic findings associated with pediatric TIO.
Assuntos
Tumores de Células Gigantes/complicações , Neoplasias Mandibulares/complicações , Neoplasias Maxilares/complicações , Osteomalacia/etiologia , Síndromes Paraneoplásicas/etiologia , Alopecia/etiologia , Calcitriol/uso terapêutico , Pré-Escolar , Terapia Combinada , Procedimentos Cirúrgicos de Citorredução , Diagnóstico Diferencial , Fator de Crescimento de Fibroblastos 23 , Fatores de Crescimento de Fibroblastos/biossíntese , Geno Valgo/etiologia , Tumores de Células Gigantes/tratamento farmacológico , Tumores de Células Gigantes/metabolismo , Tumores de Células Gigantes/cirurgia , Humanos , Hipofosfatemia/etiologia , Injeções Intralesionais , Masculino , Neoplasias Mandibulares/tratamento farmacológico , Neoplasias Mandibulares/metabolismo , Neoplasias Mandibulares/cirurgia , Neoplasias Maxilares/tratamento farmacológico , Neoplasias Maxilares/metabolismo , Neoplasias Maxilares/cirurgia , Proteínas de Neoplasias/biossíntese , Úlceras Orais/etiologia , Osteomalacia/diagnóstico , Osteomalacia/tratamento farmacológico , Síndromes Paraneoplásicas/diagnóstico , Síndromes Paraneoplásicas/tratamento farmacológico , Fósforo/uso terapêutico , Raquitismo/diagnóstico , Triancinolona/administração & dosagem , Triancinolona/uso terapêuticoRESUMO
Necrosis of the oral mucosa following head and neck cancer radiation therapy presents considerable clinical management challenges. We report three cases of symptomatic persisting oral ulcerations where the addition of photobiomodulation therapy resulted in a rapid resolution of the oral lesions and in patient symptoms. These cases suggest that photobiomodulation may represent an adjunct to care of these difficult to manage complications in oncology.
Assuntos
Neoplasias de Cabeça e Pescoço/radioterapia , Terapia com Luz de Baixa Intensidade/métodos , Úlceras Orais/radioterapia , Lesões por Radiação/radioterapia , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/patologia , Mucosa Bucal/efeitos da radiação , Necrose , Úlceras Orais/etiologia , Orofaringe/patologia , Orofaringe/efeitos da radiação , Lesões por Radiação/etiologiaRESUMO
OBJECTIVE: The aim of this study is to assess the effect of two types of antioxidants, vitamin E (VE) and Aloe vera (AV), on healing of induced oral lesions after radiation in a murine model by clinical and histological analysis. METHODS: The animals were randomly divided into three groups of 12 animals each (400 mg VE, 70 % AV and control) and two time periods (5 and 7 days). They were irradiated with a single dose of 30 Gy, and after 24 h, a lesion was produced on the ventral tongue of each animal. The products were applied daily in their respective group until euthanasia. RESULTS: On clinical analysis, there was a higher frequency of lesions in the animals of the control group at both periods. The area of the lesions was also greater in the control group compared with the groups AV and VE (5 days p = 0.006; 7 days p = 0.002). On microscopic analysis, the degree of inflammation differed between the study groups and experimental periods. At 5 days, the statistical difference was not significant among the groups evaluated, but at 7 days, animals in the control group showed intense inflammation, while those in groups VE and AV exhibited mild to moderate inflammation (p = 0.002). CONCLUSION: The results suggest that VE and AV contributed to the decrease in inflammatory response and healing of the lesions induced on the tongue of rats subjected to radiation.
Assuntos
Aloe , Úlceras Orais/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Lesões Experimentais por Radiação/tratamento farmacológico , Doenças da Língua/tratamento farmacológico , Vitamina E/administração & dosagem , Administração Tópica , Animais , Antioxidantes/administração & dosagem , Modelos Animais de Doenças , Feminino , Masculino , Úlceras Orais/etiologia , Distribuição Aleatória , Ratos , Ratos Wistar , Doenças da Língua/etiologia , Cicatrização/efeitos dos fármacosRESUMO
OBJECTIVE: The aim of this study was to evaluate the efficacy of Er,Cr:YSGG laser irradiation in reducing pain and on healing rate of traumatic ulcerations (TU) during a 2-week period after placement of new complete dentures. BACKGROUND DATA: Denture-related TU are painful, and result in patient discomfort. Lasers are used in the treatment of different kinds of mucosal lesions; however, there are no published data available concerning the clinical outcome of the use of laser therapy in the treatment of TU. MATERIALS AND METHODS: Thirty edentulous patients with newly fabricated complete dentures who subsequently developed one or more pairs of TU participated in this study. For each patient, ulcerations were randomly assigned to the test and control groups. In the test group, ulcerations were irradiated with Er,Cr:YSGG laser. In the control group, the same laser without laser emission was used. Pain was assessed with a visual analog scale (VAS). Healing of ulcerations (HU) was graded by a clinician. RESULTS: In the test group, laser irradiation provided significantly reduced pain immediately after treatment, and provided a significant healing effect 1 day after treatment, and these effects were maintained throughout the study. In the control group, baseline VAS scores were not statistically significant at baseline and 1 day after treatment, and HU scores were statistically significant 3, 7, and 14 days after treatment. Intergroup comparisons revealed that the differences in VAS and HU scores were statistically significant for all time periods after treatment, except for day 14. CONCLUSIONS: Based on these findings, it may be concluded that Er,Cr:YSGG laser is effective in the treatment of TU.
Assuntos
Dentaduras/efeitos adversos , Lasers de Estado Sólido/uso terapêutico , Terapia com Luz de Baixa Intensidade , Úlceras Orais/etiologia , Úlceras Orais/radioterapia , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Úlceras Orais/patologiaRESUMO
BACKGROUND: Treatment of cancer is increasingly more effective but is associated with short and long term side effects. Oral side effects remain a major source of illness despite the use of a variety of agents to prevent them. One of these side effects is oral mucositis (mouth ulcers). OBJECTIVES: To evaluate the effectiveness of prophylactic agents for oral mucositis in patients with cancer receiving treatment, compared with other potentially active interventions, placebo or no treatment. SEARCH STRATEGY: Electronic searches of Cochrane Oral Health Group and PaPaS Trials Registers (to 16 February 2011), CENTRAL (The Cochrane Library 2011, Issue 1), MEDLINE via OVID (1950 to 16 February 2011), EMBASE via OVID (1980 to 16 February 2011), CINAHL via EBSCO (1980 to 16 February 2011), CANCERLIT via PubMed (1950 to 16 February 2011), OpenSIGLE (1980 to 2005) and LILACS via the Virtual Health Library (1980 to 16 February 2011) were undertaken. Reference lists from relevant articles were searched and the authors of eligible trials were contacted to identify trials and obtain additional information. SELECTION CRITERIA: Randomised controlled trials of interventions to prevent oral mucositis in patients receiving treatment for cancer. DATA COLLECTION AND ANALYSIS: Information regarding methods, participants, interventions, outcome measures, results and risk of bias were independently extracted, in duplicate, by two review authors. Authors were contacted for further details where these were unclear. The Cochrane Collaboration statistical guidelines were followed and risk ratios calculated using random-effects models. MAIN RESULTS: A total of 131 studies with 10,514 randomised participants are now included. Overall only 8% of these studies were assessed as being at low risk of bias. Ten interventions, where there was more than one trial in the meta-analysis, showed some statistically significant evidence of a benefit (albeit sometimes weak) for either preventing or reducing the severity of mucositis, compared to either a placebo or no treatment. These ten interventions were: aloe vera, amifostine, cryotherapy, granulocyte-colony stimulating factor (G-CSF), intravenous glutamine, honey, keratinocyte growth factor, laser, polymixin/tobramycin/amphotericin (PTA) antibiotic pastille/paste and sucralfate. AUTHORS' CONCLUSIONS: Ten interventions were found to have some benefit with regard to preventing or reducing the severity of mucositis associated with cancer treatment. The strength of the evidence was variable and implications for practice include consideration that benefits may be specific for certain cancer types and treatment. There is a need for further well designed, and conducted trials with sufficient numbers of participants to perform subgroup analyses by type of disease and chemotherapeutic agent.
Assuntos
Antineoplásicos/efeitos adversos , Candidíase Bucal/prevenção & controle , Neoplasias/terapia , Úlceras Orais/prevenção & controle , Estomatite/prevenção & controle , Candidíase Bucal/etiologia , Humanos , Úlceras Orais/etiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Estomatite/etiologiaRESUMO
Radiotherapy produces both acute and delayed effects on mucosal tissues, disturbing their healing. This report shows a successful treatment with laser phototherapy (LPT) on a delayed wound healing in oral mucosa previously submitted to radiotherapy with a follow up of 3 years. A 47-year-old patient treated 6 months earlier for tongue squamous cell carcinoma by surgery and radiotherapy presented with a mass in the operated area. Biopsy showed chronic inflammatory infiltrate around a residual polyglactin suture. After 2 months there was a painful mucosal dehiscence on the biopsy site. LPT was performed using a semiconductor laser with 660-nm wavelength (InGaAlP) and spot size of 0·04 cm(2) . The parameters applied were 40 mW, 4 Jcm(2) /point, 0·16 J/point, 2·4 J/session. The irradiation was performed punctually, through contact mode in 15 points (4 seconds/point), on top of and around the lesion, during ten sessions. The wound healed completely after ten sessions. This treatment proved to be conservative and effective, inducing healing of a chronic wound in a tissue previously submitted to radiotherapy.
Assuntos
Irradiação Craniana/efeitos adversos , Lasers Semicondutores/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Mucosa Bucal/efeitos da radiação , Úlceras Orais/radioterapia , Lesões por Radiação/radioterapia , Cicatrização/efeitos da radiação , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/radioterapia , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/patologia , Úlceras Orais/etiologia , Úlceras Orais/patologia , Lesões por Radiação/patologia , Fatores de Tempo , Neoplasias da Língua/diagnóstico , Neoplasias da Língua/radioterapiaAssuntos
Artrite Reumatoide/tratamento farmacológico , Transtornos de Enxaqueca/prevenção & controle , Fitoterapia , Tanacetum parthenium , Aspirina , Interações Medicamentosas , Gastroenteropatias/etiologia , Humanos , Hipersensibilidade/etiologia , Úlceras Orais/etiologia , Fitoterapia/efeitos adversos , Preparações de Plantas/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto , Tanacetum parthenium/efeitos adversos , VarfarinaRESUMO
BACKGROUND: Treatment of cancer is increasingly more effective but is associated with short and long term side effects. Oral side effects remain a major source of illness despite the use of a variety of agents to prevent them. One of these side effects is oral mucositis (mouth ulcers). OBJECTIVES: To evaluate the effectiveness of prophylactic agents for oral mucositis in patients with cancer receiving treatment, compared with other potentially active interventions, placebo or no treatment. SEARCH STRATEGY: Electronic searches of Cochrane Oral Health Group and PaPaS Trials Registers (to 1 June 2010), CENTRAL (The Cochrane Library 2010, Issue 2), MEDLINE via OVID (1950 to 1 June 2010), EMBASE via OVID (1980 to 1 June 2010), CINAHL via EBSCO (1980 to 1 June 2010), CANCERLIT via PubMed (1950 to 1 June 2010), OpenSIGLE (1980 to 2005) and LILACS via the Virtual Health Library (1980 to 1 June 2010) were undertaken. Reference lists from relevant articles were searched and the authors of eligible trials were contacted to identify trials and obtain additional information. SELECTION CRITERIA: Randomised controlled trials of interventions to prevent oral mucositis in patients receiving treatment for cancer. DATA COLLECTION AND ANALYSIS: Information regarding methods, participants, interventions, outcome measures, results and risk of bias were independently extracted, in duplicate, by two review authors. Authors were contacted for further details where these were unclear. The Cochrane Collaboration statistical guidelines were followed and risk ratios calculated using random-effects models. MAIN RESULTS: A total of 131 studies with 10,514 randomised participants are now included. Nine interventions, where there was more than one trial in the meta-analysis, showed some statistically significant evidence of a benefit (albeit sometimes weak) for either preventing or reducing the severity of mucositis, compared to either a placebo or no treatment. These nine interventions were: allopurinol, aloe vera, amifostine, cryotherapy, glutamine (intravenous), honey, keratinocyte growth factor, laser, and polymixin/tobramycin/amphotericin (PTA) antibiotic pastille/paste. AUTHORS' CONCLUSIONS: Nine interventions were found to have some benefit with regard to preventing or reducing the severity of mucositis associated with cancer treatment. The strength of the evidence was variable and implications for practice include consideration that benefits may be specific for certain cancer types and treatment. There is a need for further well designed, and conducted trials with sufficient numbers of participants to perform subgroup analyses by type of disease and chemotherapeutic agent.
Assuntos
Antineoplásicos/efeitos adversos , Candidíase Bucal/prevenção & controle , Neoplasias/terapia , Estomatite/prevenção & controle , Candidíase Bucal/etiologia , Humanos , Mucosa Bucal , Úlceras Orais/etiologia , Úlceras Orais/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto , Estomatite/etiologiaRESUMO
PEPPERMINT (Mentha piperita) is a popular herb that can be used in numerous forms (ie, oil, leaf, leaf extract, and leaf water). Peppermint oil has the most uses, and use data on the oil are considered relevant to the leaf extract formulations as well. This herbal preparation is used in cosmeceuticals, personal hygiene products, foods, and pharmaceutical products for both its flavoring and fragrance properties. Peppermint oil possesses a fresh sharp menthol odor and a pungent taste followed by a cooling sensation. It also has a variety of therapeutic properties and is used in aromatherapy, bath preparations, mouthwashes, toothpastes, and topical preparations. Topical preparations of peppermint oil have been used to calm pruritus and relieve irritation and inflammation. Their frequent application to impaired skin could contribute to the sensitization rates seen. Numerous allergic contact dermatitis reactions to peppermint oil have been described, many of which are linked to both perioral and intraoral disorders. Although peppermint oil is known for its many properties, its role as a sensitizer should be recognized so as to aid in the diagnosis of both dermatitis and oral conditions and to allow the initiation of proper avoidance measures.
Assuntos
Síndrome da Ardência Bucal/etiologia , Dermatite Alérgica de Contato/etiologia , Mentha piperita , Óleos Voláteis/efeitos adversos , Úlceras Orais/etiologia , Óleos de Plantas/efeitos adversos , Alérgenos/efeitos adversos , Cosméticos/efeitos adversos , Cosméticos/química , Humanos , Óleos Voláteis/uso terapêutico , Óleos de Plantas/uso terapêuticoRESUMO
BACKGROUND: Treatment of cancer is increasingly effective but associated with short and long term side effects. Oral side effects, including oral mucositis (mouth ulceration), remain a major source of illness despite the use of a variety of agents to treat them. OBJECTIVES: To assess the effectiveness of interventions for treating oral mucositis or its associated pain in patients with cancer receiving chemotherapy or radiotherapy or both. SEARCH STRATEGY: Electronic searches of Cochrane Oral Health Group and PaPaS Trials Registers (to 1 June 2010), CENTRAL via The Cochrane Library (to Issue 2, 2010), MEDLINE via OVID (1950 to 1 June 2010), EMBASE via OVID (1980 to 1 June 2010), CINAHL via EBSCO (1980 to 1 June 2010), CANCERLIT via PubMed (1950 to 1 June 2010), OpenSIGLE (1980 to 1 June 2010) and LILACS via the Virtual Health Library (1980 to 1 June 2010) were undertaken. Reference lists from relevant articles were searched and the authors of eligible trials were contacted to identify trials and obtain additional information. SELECTION CRITERIA: All randomised controlled trials comparing agents prescribed to treat oral mucositis in people receiving chemotherapy or radiotherapy or both. Outcomes were oral mucositis, time to heal mucositis, oral pain, duration of pain control, dysphagia, systemic infection, amount of analgesia, length of hospitalisation, cost and quality of life. DATA COLLECTION AND ANALYSIS: Data were independently extracted, in duplicate, by two review authors. Authors were contacted for details of randomisation, blindness and withdrawals. Risk of bias assessment was carried out on six domains. The Cochrane Collaboration statistical guidelines were followed and risk ratio (RR) values calculated using fixed-effect models (less than 3 trials in each meta-analysis). MAIN RESULTS: Thirty-two trials involving 1505 patients satisfied the inclusion criteria. Three comparisons for mucositis treatment including two or more trials were: benzydamine HCl versus placebo, sucralfate versus placebo and low level laser versus sham procedure. Only the low level laser showed a reduction in severe mucositis when compared with the sham procedure, RR 5.28 (95% confidence interval (CI) 2.30 to 12.13).Only 3 comparisons included more than one trial for pain control: patient controlled analgesia (PCA) compared to the continuous infusion method, therapist versus control, cognitive behaviour therapy versus control. There was no evidence of a difference in mean pain score between PCA and continuous infusion, however, less opiate was used per hour for PCA, mean difference 0.65 mg/hour (95% CI 0.09 to 1.20), and the duration of pain was less 1.9 days (95% CI 0.3 to 3.5). AUTHORS' CONCLUSIONS: There is weak and unreliable evidence that low level laser treatment reduces the severity of the mucositis. Less opiate is used for PCA versus continuous infusion. Further, well designed, placebo or no treatment controlled trials assessing the effectiveness of interventions investigated in this review and new interventions for treating mucositis are needed.
Assuntos
Neoplasias/tratamento farmacológico , Neoplasias/radioterapia , Úlceras Orais/terapia , Estomatite/terapia , Analgésicos/uso terapêutico , Antiulcerosos/uso terapêutico , Humanos , Terapia com Luz de Baixa Intensidade/métodos , Doenças da Boca/etiologia , Doenças da Boca/terapia , Úlceras Orais/etiologia , Dor/etiologia , Manejo da Dor , Ensaios Clínicos Controlados Aleatórios como Assunto , Estomatite/etiologiaAssuntos
Antígenos de Plantas/efeitos adversos , Dessensibilização Imunológica/efeitos adversos , Úlceras Orais/etiologia , Faringe , Rinite Alérgica Sazonal/tratamento farmacológico , Administração Sublingual , Corticosteroides/uso terapêutico , Antígenos de Plantas/administração & dosagem , Dessensibilização Imunológica/métodos , Humanos , Úlceras Orais/tratamento farmacológico , Úlceras Orais/patologia , Phleum/imunologia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/efeitos adversos , Rinite Alérgica Sazonal/imunologia , Comprimidos , Adulto JovemRESUMO
OBJECTIVE AND BACKGROUND DATA: Common side effects of radiotherapy (RT) to the head and neck include oral mucositis, xerostomia, and severe pain. The aim of this study is to report improvement in the quality of life of an oncological patient by laser phototherapy (LPT). CLINICAL CASE AND LASER PHOTOTHERAPY PROTOCOL: The patient, a 15-year-old girl diagnosed with mucoepidermoid carcinoma, underwent surgical excision of a tumor of the left palatomaxilla. After that, she was subjected to 35 sessions of RT (2 Gy/d). Clinical examination revealed the spread of severe ulcerations to the jugal mucosa, gums, lips, hard palate, and tongue (WHO mucositis score 3). She had difficulty in moving her tongue and she was unable to eat any solid food. Oral hygiene orientation and LPT were performed throughout all RT sessions. A continuous diode laser, 660 nm, 40 mW, 6 J/cm(2), 0.24 J per point in contact mode, with spot size of 0.04 cm(2) was used in the entire oral cavity. A high-power diode laser at 1 W, 10 sec per cm of mucositis, approximately 10 J/cm(2), was used in defocused mode only on ulcerative lesions. After the first laser irradiation session, decreases in pain and xerostomia were reported; however, a more significant improvement was seen after five sessions. At that point although the mucositis score was still 2, the patient reported that she was free of pain, and consequently a palatine plate could be made to rehabilitate the entire surgical area. Seventeen laser irradiation sessions were necessary to eliminate all oral mucositis lesions. CONCLUSION: Normal oral function and consequent improvements in the quality of life of this oncologic patient were observed with LPT.
Assuntos
Carcinoma Mucoepidermoide/terapia , Neoplasias de Cabeça e Pescoço/terapia , Terapia com Luz de Baixa Intensidade , Radioterapia/efeitos adversos , Estomatite/radioterapia , Adolescente , Carcinoma Mucoepidermoide/radioterapia , Carcinoma Mucoepidermoide/cirurgia , Feminino , Neoplasias de Cabeça e Pescoço/radioterapia , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Neoplasias Maxilares/radioterapia , Neoplasias Maxilares/cirurgia , Neoplasias Maxilares/terapia , Úlceras Orais/etiologia , Úlceras Orais/radioterapia , Neoplasias Palatinas/radioterapia , Neoplasias Palatinas/cirurgia , Neoplasias Palatinas/terapia , Qualidade de Vida , Estomatite/etiologia , Xerostomia/etiologia , Xerostomia/radioterapiaRESUMO
Recurrent aphthous ulcer (RAU) is the most common ulcer of oral non-keratinized mucosa, but the treatment is always limited at present. Considering the multifactorial etiology of RAU, a novel therapeutic agent with multi-bioactivties should be presented. Garlic has been recognized as a favorable natural medicine against a large number of pathologic conditions. The major component of garlic is allicin, which could effectively decrease inflammatory factors secretion, reduce the migration of neutrophils, inhibit bacterium and virus, antagonize oxidation and regulate immunity. By these bioactivities of anti-inflammation, anti-microbial activity, anti-oxidation and immunomodulation, the allicin may be an effective therapeutic candidate to control the pain, promote ulcer healing and prevent the recurrence of RAU.
Assuntos
Úlceras Orais/tratamento farmacológico , Estomatite Aftosa/tratamento farmacológico , Ácidos Sulfínicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Dissulfetos , Alho , Humanos , Úlceras Orais/etiologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , Estomatite Aftosa/etiologia , Fator de Necrose Tumoral alfa/genéticaRESUMO
PURPOSE: To study the effect of recombinant human keratinocyte growth factor (rHuKGF or palifermin) on oral mucositis induced by radiochemotherapy in a mouse model. METHODS AND MATERIALS: Cis-diamminedichloroplatinum (cisplatin) and/or 5-fluorouracil were given before single dose irradiation, combined with palifermin before or after the treatment, or both. Daily fractionated irradiation for 2 weeks was followed by graded test doses. With additional chemotherapy in Week 1, palifermin was given before radiotherapy and at the end of the first week, or additionally at the end of Week 2. Radiochemotherapy in Week 2 was combined with palifermin at the end of Weeks 1 and 2, Weeks 1, 2, and 3, or additionally before radiotherapy. Ulceration of mouse tongue mucosa was analyzed as the endpoint. RESULTS: The dose associated with ulcer induction in 50% of the mice (ED(50)) for single-dose irradiation was 11.5 +/- 0.7 Gy. Palifermin increased the ED(50) to about 19 Gy in all protocols tested. Similar values were observed when chemotherapy was added before irradiation. With fractionated irradiation, palifermin increased the ED(50) for test irradiation from 5.7 +/- 1.5 Gy to 12-15 Gy, depending on the administration protocol. With chemotherapy in Week 1, two palifermin injections had no significant effect, but a third injection increased the ED(50) to 13 Gy. With chemotherapy in Week 2, all palifermin protocols resulted in ED(50) values of 13-14 Gy. CONCLUSION: A marked increase in oral mucosal radiation tolerance by palifermin was found, which was preserved in combinations with chemotherapy using cisplatin and/or 5-fluorouracil.